SUMMARY An investigation of serum immunoreactive trypsin concentration and pancreatic isoamylase activity in patients with diabetes mellitus has shown that exocrine pancreatic deficit is maximal in insulin dependent diabetics, intermediate in those controlled with sulphonylureas, and absent in patients controlled with biguanides or diet or both. A significant correlation between the serum concentrations of both these pancreatic enzymes and C peptide was found. Serum pancreatic enzyme concentrations were not related to glycosylated haemoglobin concentrations, the dosage of insulin, or the age of onset of diabetes. The concentration of immunoreactive trypsin was found to be low in most of the insulin dependent diabetics in whom this enzyme was measured at the time of the clinical onset of diabetes. Thus exocrine pancreatic deficit in diabetes closely parallels the endocrine ,8 cell deficit and occurs concurrently with, or antedates, the clinical presentation of type I diabetes. It is therefore possible that in type I diabetes similar mechanisms are entailed in the pathogenesis of impaired endocrine and exocrine pancreatic function.
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Exocrine pancreatic function is impaired in insulin dependent diabetics. This conclusion is supported by direct measurement of pancreatic enzyme concentrations in duodenal aspirates ' and by the finding of low serum concentrations of immunoreactive trypsin and pancreatic isoamylase activity45 in such patients. Measurement of these pancreatic enzymes in the serum also showed diminished exocrine pancreatic reserve in diabetics treated with sulphonylureas but not in those controlled by biguanides or diet. 24 These results suggested correlation of exocrine and endocrine pancreatic reserve.
The present study confirms such a correlation and also assesses the pancreatic exocrine deficit in relation to the clinical onset of insulin dependent diabetes. The effect of duration, age of onset, and quality of control of diabetes on exocrine pancreatic function was also studied.
Patients, material and methods
Eighty seven diabetic patients were studied: 44 insulin dependent diabetics, 27 patients controlled with sulphonylureas (with or without biguanides), and 16 patients treated with biguanides or diet alone. FifAccepted for publication 23 November 1983 teen of the insulin dependent diabetics were investigated at the time of clinical onset of diabetes. Six patients were studied at a stage when they had ceased to respond to oral hypoglycaemic agents and were due for a change in insulin treatment.
Four patients had immunoreactive trypsin concentrations measured in samples obtained on admission to hospital, a week later, and at least six weeks after an acute episode of diabetic ketoacidosis.
Serum samples were obtained from these patients between 10.00 and 11.00 am, before their morning dose of insulin or drugs and breakfast. The samples were frozen immediately at -40°C until they were assayed for immunoreactive trypsin and pancreatic isoamylase. Another sample of heparinised plasma was also obtained and stored at 4°C until haemoglobin A, concentration was measured (within 24 h).
Immunoreactive trypsin concentration was measured in all sera as previously described, using a radioimmunoassay kit (Hoechst, UK).2 Pancreatic isoamylase activity was measured in 37 sera by the electrophoretic separation of amylase isoenzymes.6 C peptide concentration was measured in 33 sera using a RIA kit (Novo, Denmark). ' C peptide concentration was lower than normal (less than 0-14 nmolI1) in 80% of insulin dependent diabetics; in one patient it was unexpectedly high. All patients treated with sulphonylureas had concentrations well within the normal reference range (0.14-0.5 nmolI1). There was a significant correlation (r = 0-54; n = 18; p < 0.01) between serum immunoreactive trypsin and C peptide concentration in insulin dependent diabetics (Fig. 2) . A correlation between pancreatic isoamylase activity and C peptide concentration (r = 059; p < 0.01) was also found (Fig. 3) ; this correlation was found even when insulin dependent diabetics and sulphonylurea treated patients were pooled together (r = 0-6; n = 30; p < 0-01; Fig. 4 ). The correlation between C peptide immunoreactive trypsin concentration and Exocrine pancreatic function in diabetes mellitus finding that immunoreactive trypsin concentrations and pancreatic isoamylase activities are significantly reduced in insulin dependent diabetics and slightly, but also significantly, reduced in patients controlled with sulphonylureas. ' 2 They are also consistent with the significantly lower pancreatic lipase activities in sera of diabetic patients when compared with controls.9 The present study has shown that there is a significant correlation between the pancreatic enzyme activities and C peptide concentration. There is thus a parallelism between the reduction in endocrine and exocrine pancreatic Ifunction, although the decreased endocrine function is much more pronounced than the decreased exocrine function. This is the converse of what we have recently shown in patients with cystic fibrosis'0 '2 and ,8-thalassaemia major with iron overload,'3 14 in whom the main target of damage is the exocrine pancreatic tissue and the evidence of endocrine injury,'5-'7 though present, is less pronounced.
The correlation between the endocrine and exocrine function in diabetes mellitus suggested that the fall in exocrine reserve might be the result of diabetes and lack of insulin. Such an interpretation is supported by the fact that insulin stimulates the secretion of enzymes by pancreatic acinar cells. '8 Although the concentrations of insulin required to exert this effect are extremely high, it could be argued that such concentrations probably do exist in the vicinity of the islets of Langerhans, owing to local diffusion of hormone from ,3 cells. Furthermore, pancreatic acinar cells have recently been shown to possess insulin receptors. '9 Most of the insulin dependent diabetics (73%) investigated at the time of onset of diabetes, however, had considerably reduced serum immunoreactive trypsin concentrations; it is therefore likely that the exocrine deficit is not a consequence of lack of insulin or diabetes, but that a common pathological process simultaneously affects the endocrine and exocrine components of the pancreas. Further investigation of exocrine pancreatic reserve in populations at risk of developing diabetes will clarify this point. Our preliminary studies on families which include two or more diabetics have shown evidence of exocrine pancreatic injury in the absence of glucose intolerance (unpublished data Another possible factor which may account for the diminished exocrine pancreatic function and hence the low pancreatic enzyme activity in sera of diabetic patients is human pancreatic polypeptide. Pancreatic polypeptide concentration is raised in diabetics (more so in insulin dependent diabetics), 2' and, furthermore, it In conclusion, the degree of impairment of exocrine pancreatic function, as reflected in serum immunoreactive trypsin concentration and pancreatic isoamylase activity, paralleled the reduction in , / cell function in diabetics in general and in insulin dependent diabetics in particular. Since the impairment was also present at the time of clinical onset of diabetes, it is possible that the mechanisms underlying the injury to the f8 cell-genetic, autoimmune, and viral-may also be relevant to the impaired function of the pancreatic acinar cell.
